Molecular mechanism of modified Yigong San formula against colorectal cancer via EZH2/METTL3/SOX4 pathway-mediated apoptosis

Figure 6 Apoptosis rates of cells in different groups. A: Flow cytometry (FCM) analysis results of the control group; B: FCM analysis results of the control + Chinese medicine group; C: FCM analysis results of the control + negative control group; D: FCM analysis results of the control + overexpressing enhancer of zeste homolog 2 group; E: FCM analysis results of the control + overexpressing enhancer of zeste homolog 2 + Chinese medicine group; F: Quantitative analysis of FCM results. ^aP < 0.0001; ^bP < 0.0001; ^cP < 0.0001. NC: Negative control; YGS: Yigong San; OE: Overexpressing; EZH2: Enhancer of zeste homolog 2.